U.S. Direct-to-Consumer (DTC) Lab Testing Market

Dublin, June 10, 2022 (GLOBE NEWSWIRE) — The “US Direct-to-Consumer (DTC) Lab Testing Market” report has been added to from ResearchAndMarkets.com offer.

Direct-to-consumer lab testing is also known as patient-ordered lab testing. A variety of tests are now available for direct-to-consumer testing.

The growing market for direct-to-consumer laboratory tests can drive awareness of health issues and genetic diseases, allowing patients to take a more proactive role in their healthcare.

With advances in technology, the completion of human genome sequencing, and the pressures of the pandemic, direct-to-consumer lab testing is becoming increasingly popular. Yet, clinical laboratories are an essential part of the healthcare industry. It is estimated that the vast majority of doctors’ diagnoses are the result of laboratory tests. In addition to diagnosing patients, clinical laboratory tests are performed to assess disease progression, monitor drug treatment and conditions, determine individual therapy, and several other reasons.

Several trends continue to shape the direct-to-consumer laboratory testing market, including growing demand for early disease detection and diagnosis, personalized medicine, importance of disease surveillance, consumer acceptance, and expanded technologies. . The report examines these and other key market trends.

Additionally, issues and trends explored in this report include:

  • Demography and aging of the population
  • Growing incidence of disease
  • Regulatory environment
  • Consumer-centred health care
  • Emphasis on preventive health care
  • Developments in personalized medicine
  • Mobile devices
  • Informed consent
  • Payment structure
  • Sales by distribution channel
  • Major Diagnostics and DTC Companies
  • Telehealth and DTC tests

Key companies profiled in the report include:

  • 23andme
  • Any lab test now
  • Color genomics
  • Direct laboratory services
  • EasyDNA
  • Everlywell
  • Laboratory Society of America
  • MyMedLab
  • Medichecks.com
  • Shadow Gut Health (formerly Thryve)
  • Quest Diagnosis
  • Request a trial

The base year for the data was 2021. The forecast years are 2022-2026 with compound annual growth rates (CAGR) provided for the periods 2021-2026 for each segment covered. The market analysis planned for 2021-2026 was largely based on demographic trends, new developments and innovative technologies.

Main topics covered:

Chapter 1: Executive Summary

  • Market size and growth
  • Scope and methodology
  • Major issues and trends affecting the market
  • Main market players
  • conclusion

Chapter 2: Overview

  • The American laboratory services industry
  • DTC Testing Market Growth
  • Structure of the laboratory industry in the United States
  • CLIA Laboratories Registration, Laboratories by Type
  • Direct-to-consumer testing
  • DTP in genetic testing
  • New opportunities in direct-to-consumer outlets
  • Dialysis clinics
  • Hospitals
  • Regulations in the laboratory industry
  • Waiver Certificate
  • Tests developed in the laboratory
  • State-by-State Assessments
  • Testing and services

Chapter 3: Direct-to-consumer routine clinical laboratory tests

  • Routine testing
  • Blood cell count
  • Cholesterol level test
  • diabetes test
  • HIV testing
  • Pregnancy test
  • Addiction tests
  • Urine analysis
  • COVID-19[feminine]
  • Saliva test
  • DTC Routine Clinical Laboratory Market Drivers and Barriers
  • Market size and growth
  • Competitive landscape

Chapter 4: Direct-to-consumer Genetic Laboratory Testing Market

  • Genetic research
  • DTC Genetic Testing Market Growth
  • Types of DTC Genetic Tests
  • Evolution of DTP Genetic Testing
  • DTC Genetic Testing Business Model
  • Market constraints
  • DTC Genetic Laboratory Testing Market Drivers and Barriers
  • Market size and growth
  • Competitive landscape

Chapter 5: Industry Drivers and Barriers

  • Issues and trends driving the direct-to-consumer market
  • Consumer-centred health care
  • Affordability and accessibility
  • Privacy
  • Aging of the population
  • Increase in chronic diseases
  • Emphasis on preventive health care
  • Regulatory environment
  • Regulatory route
  • Precision
  • Informed consent
  • Payment structure for direct-to-consumer lab testing
  • Direct payment to patients
  • Flexible Spending Accounts and Health Savings Accounts
  • Sales by distribution channel
  • Mobile devices
  • Major Diagnostics and DTC Companies
  • Telehealth and DTC tests

Chapter 6: Company Profiles

  • 23andme
  • Any lab test now
  • Color genomics
  • Direct laboratory services
  • EasyDNA
  • Everlywell
  • Laboratory Society of America
  • MyMedLab
  • Medichecks.com
  • Shadow Gut Health (formerly Thryve)
  • Quest Diagnosis
  • Request a trial

For more information on this report, visit https://www.researchandmarkets.com/r/fm5dny

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.


        

About Hector Hedgepeth

Check Also

Experts explain the ‘perfect storm’ of endemic RSV and influenza

The headlines of the past few weeks are sounding the alarm about earlier and more …